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Abstract
Background: In some patients with COPD, the disease is characterized by exacerbations. Severe exacerbations
warrant a hospitalization, with prolonged detrimental effects on physical activity. Interventions after an exacerbation
may improve physical activity, with longstanding health benefits. Physical activity counseling and real-time feedback
were effective in stable COPD. No evidence is available on the use of this therapeutic modality in patients after a
COPD exacerbation.
Methods: Thirty patients were randomly assigned to usual care or physical activity counseling, by telephone
contacts at a frequency of 3 times a week and real-time feedback. Lung function, peripheral muscle strength,
functional exercise capacity, symptom experience and COPD-related health status were assessed during hospital
stay and 1 month later.
Results: Both groups significantly recovered in physical activity (PAsteps: control group: 1013 ± 1275 steps vs intervention
group: 984 ± 1208 steps (p = 0.0005); PAwalk: control group: 13 ± 14 min vs intervention group: 13 ± 16 min (p = 0.0002)),
functional exercise capacity (control group: 64 ± 59 m (p= 0.002) vs intervention group: 67 ± 84 m (p = 0.02)) and COPD-
related health status (CAT: control group: −5 [−7 to 1] (p = 0.02) vs intervention group: −3 [−10 to 1] points (p = 0.03)). No
differences between groups were observed.
Conclusion: From our pilot study, we concluded that telephone based physical activity counseling with pedometer
feedback after an exacerbation did not result in better improvements in physical activity and clinical outcomes compared
to usual care. Because of the difficult recruitment and the negative intermediate analyses, this study was not continued.
Trial registration: Clinicaltrials.gov NCT02223962. Registered 4 September 2013.
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Background
Chronic Obstructive Pulmonary Disease (COPD) is char-
acterized by exacerbations. These episodes of worsening
of symptoms beyond the expected daily variation lead to
substantial morbidity and mortality. Exacerbations accel-
erate disease progression and they have a negative impact
on the quality of life of patients [1–5]. Severe exacerba-
tions of COPD require a hospitalization, imposing a real
burden on the socioeconomic system [1, 4]. During the
hospital stay, patients are severely inactive, with a reper-
cussion on their muscle strength and exercise capacity [6].
Physical activity (PA) levels of these patients are below the
levels found in stable patients with COPD, even 1 month
after discharge [7]. Immediately after their return home,
patients experience several barriers to engage in PA, such
as anxiety for dyspnea, the need for oxygen and environ-
mental factors such as the weather [8]. Nevertheless,
sustaining a physically inactive lifestyle increases the
risk for a new hospital admission [9], increases mor-
tality rates [9, 10] and has a negative impact on the onset
and progression of comorbid conditions [11, 12]. These
findings warrant the measurement and enhancement of
PA after hospital discharge. So far, studies concentrated
on formal pulmonary rehabilitation to improve physical
activity after exacerbations, with inconsistent effects [12].
From the 10 studies [13–22] that have been published on
this topic, 4 studies [17–19, 22] showed an increased level
of physical activity after pulmonary rehabilitation. Further-
more, such programs may suffer from poor uptake, adher-
ence and lack of accessibility [23]. Only 34 % (range 18 to
67 %) of eligible patients eventually participate in pulmon-
ary rehabilitation [23–27]. Therefore, there is an urgent
need for other interventions to promote physical activity
after an exacerbation. In stable patients with COPD, nor-
dic walking [28] was investigated and was found to be suc-
cessful. PA counseling combined with real-time feedback
has proven its effect in improving PA in healthy subjects
[29], in patients with heart failure [30, 31], diabetes [11]
and in stable patients with COPD. The use of the latter
treatment modality has not been explored in patients im-
mediately after a hospitalization for an acute exacerbation
of COPD [32–34]. For this pilot study, we hypothesized
that, through frequent PA counseling and real-time feed-
back, patients would potentially increase their PA level
more rapidly in the month after an exacerbation com-
pared to subjects in a control group, receiving usual care.
Methods
Subjects
Patients with COPD, hospitalized for an exacerbation of
COPD were informed about the study and were included
when the following inclusion criteria were met: 1) Male/
female > 40 years of age 2) Diagnosis of COPD, defined as
FEV1/FVC < 70 % (post-bronchodilation) 3) Hospitalized
for a COPD exacerbation 4) Ability to work with elec-
tronic devices. Patients were excluded if they participated
in pulmonary rehabilitation prior to the index hospital ad-
mission (and would return to the program after discharge)
or suffered from a neurological or musculoskeletal disease
that would prevent them from being active. The protocol
was approved by the local medical ethics committee from
the University Hospitals KULeuven and all patients gave
their written informed consent.
Sample size calculation
The sample size calculation was performed using
G*Power (version 3.1.6). Based on previous research, we
assumed the intervention group to reach a walking time
that equals the walking time in stable patients with
COPD (44 ± 20 min) [35]. The control group was esti-
mated to achieve 28 ± 20 min of walking time, which
corresponds to the amount of walking time in patients
1 month after hospitalization for an exacerbation [7].
With a degree of certainty (statistical power) of 80 %
and a risk for a type I error (α) < 5 %, 26 patients in both
groups were needed. Considering a drop out rate of
20 % [34], the total sample size of the study was esti-
mated at 62 patients with COPD.
Study design
Fifty-three patients, hospitalized for an exacerbation in
the University Hospital of Leuven, were informed about
the study and eventually 30 patients were willing to par-
ticipate. Patients were recruited from April 2013 to April
2014. Eligible patients were randomized (randomization
rate of 1:1) into usual care or were provided with a ped-
ometer to provide real-time feedback on physical activity
and personal, telephone based PA counseling during
1 month. The intervention started from the moment of
discharge. After 1 month, all patients were offered the
opportunity to be enrolled in pulmonary rehabilitation.
A consort diagram is provided in Fig. 1.
Intervention
Physical activity counseling and real-time feedback
Physical activity measurement and real-time feed-
back The Fitbit Ultra® (Fitbit Inc, San Francisco, Califor-
nia), a pedometer, was used to provide real-time feedback
based on step counts. Based on a pilot study, we decided
to clip the Fitbit Ultra® on the right sock in these slowly
walking patients to pick up a maximal amount of steps.
Because the Fitbit Ultra® is not validated in COPD, pa-
tients wore the latter device simultaneously with the
Dynaport MoveMonitor (McRoberts BV, The Hague, the
Netherlands), a valid activity monitor in COPD [36] at 3
time points during the study (during hospital stay, 2 weeks
after discharge and at the end of the study).
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Physical activity counseling Telephone calls, with a
frequency of 3 times a week, were used as a means
to motivate and stimulate patients in the intervention
group to increase their PA level during 1 month (11 ± 1
calls/patient on average). The timing of the telephone
calls was determined in agreement with the patients.
During these telephone contacts, step counts of the
previous days were discussed with an experienced
physiotherapist as well as barriers and opportunities
for PA. At the end of the telephone call, a new goal
was agreed for the following days. The goals were set
individually, with the aim of improving the level of
PA as much as possible during 1 month. Two and
4 weeks after hospital discharge, a progression report
including further tips to increase PA was sent by post
to the patients.
Usual care
Patients in the control group did not participate in
any kind of rehabilitation, were not contacted nor re-
ceived motivational messages. They were provided
with advice about increasing PA during the hospital
stay from a physiotherapist. Two weeks after hospital
discharge and at the end of the study, patients were
asked to wear the Dynaport MoveMonitor during 7
consecutive days.
A more detailed description of the study protocol is
depicted in Fig. 2.
Measurements
Physical activity was the primary outcome of the study
and was measured during hospital stay, 2 weeks after
discharge and at the end of the study. Measurements of
lung function, peripheral muscle strength, functional ex-
ercise capacity, symptoms of dyspnea and COPD-related
health status were secondary outcomes of the study and
were performed during hospital stay (the day before dis-
charge) and 1 month later, at the end of the study.
Physical activity
The measurements were performed with the Dynaport
MoveMonitor (McRoberts BV, The Hague, the Netherlands).
This device was recently validated in patients with COPD
[36]. The Dynaport MoveMonitor is a small (64x62x13mm)
and lightweight device (68 g, including batteries). Analysis
of raw data allows for classification of intensity, duration
and frequency of movement. Different postures and walk-
ing are identified and energy expenditure is estimated.
The Dynaport MoveMonitor is inserted in an elastic belt
and positioned on the lower back at the height of the sec-
ond lumbar vertebra, nearby the body’s center of mass, ac-
cording to the instructions of the manufacturer. Data on
walking time (PAwalk), daily amount of steps (PAsteps)
and movement intensity during walking (PAint) were used
for the analyses.
Lung function
All patients performed post-bronchodilator spirom-
etry according to European Respiratory Society and
American Thoracic Society standards [37]. The re-
sults were referred to the predicted values reported
by Quanjer et al. [38].
Fig. 1 Consort diagram of the study
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Peripheral muscle strength
Isometric quadriceps strength (QF) was measured
using a dynamometer (Biodex system 4 pro; Enraf
Nonius; Delft, The Netherlands). Peak extension torque
was evaluated at 60° of knee flexion. After a practice
trial, tests were performed at least 3 times and the
best result was used for further analyses [18]. Refer-
ence values for the quadriceps strength were devel-
oped in our laboratory [39].
Functional exercise capacity
Functional exercise performance was measured by a
six minutes walking distance test (6MWD) in a 50-m
corridor. The patients were instructed to walk the lar-
gest distance as possible during 6 min. Encourage-
ments were standardized and oxygen saturation and
heart rate were measured continuously. Patients in-
cluded in the study were all familiar with the 6MWD.
For this reason and for not burdening the patients
too much, only 1 test was executed. Normal values
were described by Troosters et al. [40].
Questionnaires
Modified medical research council dyspnea scale
(mMRC) The mMRC dyspnea scale is a questionnaire
that consists of five statements about perceived breath-
lessness. Those who grade themselves with a statement
with a higher score, experience more breathlessness dur-
ing daily activities [41].
COPD assessment test (CAT) The CAT consists of
eight items, each formatted as a semantic six-point dif-
ferential scale. The total score is calculated as the sum
of the responses. The higher the CAT score, the lower
the overall COPD-related health status. This question-
naire is valid and reliable to be used in patients with
COPD [42].
Statistical analyses
We included all evaluable patients in the statistical ana-
lyses, without excluding patients that were not compli-
ant. Patients without follow-up data were excluded.
To check for normality, a Shapiro-Wilk test was applied.
Data were expressed as mean ± SD in case of normal dis-
tribution. If the data were not normally distributed, me-
dian [IQR] were used. To compare continuous data
between the two study groups an unpaired t-test was ap-
plied. The comparison of proportions between groups was
performed using a Chi-Square test. Within group changes
during 1 month were assessed by means of a paired t-test,
using delta scores. Physical activity was measured at 3
time points. To analyze these data, a mixed model re-
peated measures ANOVA (proc mixed in SAS 9.3) was
applied and data were corrected for important baseline
differences.
Results
Baseline characteristics
Table 1 provides an overview of the baseline characteris-
tics of the study. The 2 study groups were matched in
Fig. 2 Study protocol
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terms of demographic characteristics. Functional exer-
cise capacity was low in both the control group and the
intervention group, but was significantly lower in the
intervention group compared to the control group.
PAsteps, PAwalk and PAint indicated an extreme phys-
ical inactivity at hospital discharge, but were not signifi-
cantly different between groups.
Drop out and follow-up completers
From the intervention group, 2 patients dropped out
from the study after signing the informed consent. One
patient was not motivated anymore to take part, while
the other patient reported transport difficulties. One pa-
tient from the intervention group deceased during the
study period. The final analyses were performed includ-
ing 15 patients in the control group and 12 patients in
the intervention group. From the 27 patients that com-
pleted the study, a complete dataset was available.
Change in physical activity during 1 month
Figure 3 and Table 2 show the change in physical ac-
tivity during 1 month. PAsteps and PAwalk signifi-
cantly increased over time in each group, with no
differences observed between groups (PAsteps: p = 0.96;
PAwalk: p = 0.98). The day-by-day pattern of PAsteps
measured by the Fibit Ultra during the intervention period
(mean for the whole group) is shown in Fig. 4.
Change in clinical parameters during 1 month
Functional exercise capacity significantly recovered
within each group 1 month after hospital discharge
(Δ6MWD: control group: 64 ± 59 m (p = 0.02) vs interven-
tion group: 67 ± 84 m (p = 0.02)). Physical activity counsel-
ing did not result in better improvements in functional
exercise capacity. Muscle strength did not significantly
change in each group during 1 month and was not influ-
enced by the type of intervention. The decrease in CAT
(points) was statistically and clinically [43] significant
within the 2 study groups (ΔCAT: control group: −5 [−7
to 1] points (p = 0.02) vs intervention group: −3 [−10 to 1]
points (p = 0.03)), with no between group effect (Table 3).
Hospital readmission, medication intake during 1 month
and enrollment in pulmonary rehabilitation afterwards
There was no significant difference in the amount of pa-
tients restarting oral corticosteroids during the study be-
tween the control group and the intervention group (6
(40 %) vs 5 (42 %) (p = 0.93)). Six patients (40 %) in the
control group and 4 patients (33 %) in the intervention
group were readmitted to the hospital for an acute
COPD exacerbation (p = 0.72) within the 1 month study
period. Enrollment in pulmonary rehabilitation was lim-
ited, as only 1 patient (7 %) from the control group and
3 patients (25 %) from the intervention group partici-
pated (p = 0.29).
Discussion and future plans
To our knowledge, this is the first study investigating an
alternative for conventional pulmonary rehabilitation
after an exacerbation to increase physical activity. We
investigated the use of telephone based physical activity
counseling and providing patients with a pedometer and
an agreed physical activity goal immediately after a
hospitalization for an exacerbation. Our study showed a
spontaneous but limited recovery in PA and clinical out-
comes. Contrary to our expectations, counseling and
real-time feedback did not result in better improvements
compared to the group receiving usual care. Recovery in
functional exercise capacity and COPD-related health
status were similar in both groups. The baseline physical
activity levels of the patients included in our study were
in line with the study of Pitta et al. [7] and confirm the
severe and long lasting physical inactivity during hospital
Table 1 Baseline characteristics
Control group
(N = 15)
Intervention group
(N = 15)
P-value
Demographic characteristics
Age (years) 68 ± 6 66 ± 7 0.34
BMI (kg/m2) 29 ± 5 25 ± 9 0.20
Gender (male (N (%)) 9 (60) 8 (53) 0.71
Pulmonary function
FEV1 (% predicted) 48 ± 18 38 ± 17 0.11
Tiffeneau Index (%) 47 ± 13 41 ± 14 0.28
Peripheral muscle strength
QF (Nm) 112 ± 28 84 ± 42 0.05
QF (% predicted) 85 ± 43 71 ± 38 0.38
Functional exercise
capacity
6MWD (meter) 317 ± 95 235 ± 134 0.07
6MWD (% predicted) 53 ± 16 36 ± 18 0.01
Stops during 6MWD
(amount)
0.66 ± 0.62 1.23 ± 0.92 0.15
Duration of stops (s) 38 ± 48 81 ± 61 0.08
Physical activity
PAsteps (amount/day) 1557 ± 1319 1644 ± 2751 0.93
PAwalk (minutes/day) 20 ± 17 22 ± 35 0.90
PAint (m/s2) 1.34 ± 0.50 1.46 ± 0.25 0.50
Questionnaires
mMRC (points) 2 [2–3] 3 [2–3] 0.39
CAT (points) 19 [15–22] 25 [13–28] 0.42
BMI body mass index, FEV1 forced expiratory volume in 1 s, QF quadriceps
strength, 6MWD six minutes walking distance, PAsteps daily amount of steps,
PAwalk daily walking time, PAint movement Intensity during walking, mMRC
modified medical research council dyspnea scale, CAT COPD assessment test.
Data are expressed as mean ± SD, median [IQR] or as N (%). p < 0.05
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admission and thereafter. In addition, the data of the ped-
ometer in the treatment group suggest that recovery is
gradual in the first 4 days but seems to level off. In contrary
to our expectations, relative values of peripheral muscle
strength at baseline were higher than expected in both
study groups and might be explained by the presence of
cachexia (BMI < 20 kg/m2) [44] in respectively 2 (13 %) and
3 (25 %) patients in the control and intervention group.
PA counseling and real-time feedback have been ap-
plied more successfully in stable patients with COPD
[33, 34], in other chronic disease conditions [11, 30, 31]
and in healthy subjects [29]. Motivational factors, phys-
ical as well as mental or social barriers to engage in PA
and hospital readmission are reasons that might explain
why we were unable to show that PA counseling was ef-
fective as a treatment modality in these patients. In a re-
cent study of Greening et al. [26], a first attempt was
made to investigate an alternative intervention to con-
ventional pulmonary rehabilitation to improve function
and PA during or immediately after an exacerbation.
Early rehabilitation, consisting of exercise and resistance
training, neuromuscular electrical stimulation and self-
management was started within 48 h after the exacerba-
tion and evolved in an unsupervised home-based program
after hospital discharge. The results of this study were
comparable with our study and showed a recovery in
function and PA. Early rehabilitation and unsupervised
home-based training did not result in a better recovery
compared to usual care. The study of Greening et al. [26]
therefore confirms that home based interventions to im-
prove function or PA during or immediately after hospital
admission for an exacerbation might lack efficacy. Individ-
ualized pulmonary rehabilitation after an exacerbation
may be a better approach in patients after an exacerbation.
We speculate that the current intervention could be an
alternative for patients that explicitly express a willingness
to increase PA, but cannot access a pulmonary rehabilita-
tion program. Motivation to alter PA was not an inclusion
criterion and unfortunately, motivational aspects were not
registered in the current study. One of the limitations of
our study was that we did not take into account “motiv-
ation to alter PA” as an inclusion criterion and that mo-
tivational aspects were not registered. Further, we did not
use a more interactive platform, as was applied by Moy et
al. [34]. The majority of our patients (70 %), however, did
not have internet access and although this might rapidly
change in the future, this seems currently not to be an
option. We did not have a rewarding system for people
that effectively increased PA in order to provide extrinsic
motivation and we did not combine the intervention with
home visits to overcome practical barriers for physical in-
activity and to explore concrete solutions with the patient.
The last limitation of our study was that we did not
spread the intervention over a longer time window to
allow a slower continued recovery. The fact that patients
seemed to stagnate in their PA levels, however, suggests
that not much further improvements should be expected
by simply prolonging the present intervention. In order to
improve the effectiveness of future studies, a rewarding
system, home visits and the investigation of motivational
aspects should be implemented.
Although the low sample size of the present study
limits the generalizability of the data, we concluded that
PA counseling immediately after an exacerbation is time
consuming and not effective to enhance PA or clinical
outcomes. Individualized pulmonary rehabilitation in the
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Fig. 3 Changes in physical activity during 1 month in the 2 study groups, measured by the Dynaport MoveMonitor
Table 2 Change in physical activity during 1 month measured
by the Dynaport MoveMonitor
Control group
(N = 15)
Intervention group
(N = 12)
ΔPAsteps (amount/day)
Time effect (p = 0.0005) 1013 ± 1275 984 ± 1208
ΔPAwalk (minutes/day)
Time effect (p = 0.0002) 13 ± 14 13 ± 16
ΔPAint (m/s2/day)
Time effect (p = 0.07) 0.08 ± 0.06 0.06 ± 0.05
PAsteps daily amount of steps, PAwalk daily walking time, PAint movement
Intensity during walking, Data are expressed as mean ± SD p < 0.05
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period after an exacerbation of COPD might be a better
approach.
Future plans
By executing this study, we experienced that including
patients after an exacerbation of COPD is very difficult.
After 1 year, only 30 patients agreed to participate in the
study. Intermediate analyses did not reveal better im-
provements in physical activity in the group that re-
ceived maximal counseling and real-time feedback
compared to usual care. Based on these conclusions and
the fact that the study was very time consuming for the
researcher, we decided not to continue with the study.
Conclusion
We concluded that physical activity levels, functional ex-
ercise capacity and COPD-related health status recover
1 month after an exacerbation, but that recovery is lim-
ited. Real-time feedback and physical activity counseling
is timing consuming and did not result in better im-
provements in comparison to usual care.
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